Edit
Report post Feedback

How much did Atricure make in 2024?

Worldwide revenue of $108.9 million – an increase of 16.4% year over year MASON, Ohio -- (BUSINESS WIRE)--May 1, 2024-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative

Who are the owners of AtriCure stock?

AtriCure's stock is owned by a number of institutional and retail investors. Top institutional investors include Los Angeles Capital Management LLC, which owns 0.06%.

Who is Atricure?

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use technologies for the treatment of Afib and reduction of Afib related complications.

The World's Leading Crypto Trading Platform

Get my welcome gifts